![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Once-Daily Dolutegravir(DTG; S/GSK1349572) is Non-Inferior to Raltegravir (RAL) in Antiretroviral-naïve Adults. 48 Week results from SPRING-2 (ING113086)
|
|
|
Reported by Jules Levin 19th Intl AIDS Conf Wash DC July 22-27 2012
Presented by Francois Raffi for the investigator team.
![IAC1.gif](../images/072612/072612-5/IAC1.gif)
![IAC2.gif](../images/072612/072612-5/IAC2.gif)
![IAC3.gif](../images/072612/072612-5/IAC3.gif)
![IAC4.gif](../images/072612/072612-5/IAC4.gif)
![IAC5.gif](../images/072612/072612-5/IAC5.gif)
![IAC6.gif](../images/072612/072612-5/IAC6.gif)
![IAC7.gif](../images/072612/072612-5/IAC7.gif)
![IAC8.gif](../images/072612/072612-5/IAC8.gif)
![IAC9.gif](../images/072612/072612-5/IAC9.gif)
![IAC10.gif](../images/072612/072612-5/IAC10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|